(Q39151986)

9 September 2017

title

Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody (English)

1 reference

9 September 2017

1 reference

1 reference

10

Otto C Boerman

1 reference

9 September 2017

9

Wim J G Oyen

1 reference

9 September 2017

2

Susanne Lütje

1 reference

9 September 2017

6

Gerben M Franssen

1 reference

9 September 2017

1

Catharina M van Rij

1 reference

9 September 2017

3

Cathelijne Frielink

1 reference

9 September 2017

4

Robert M Sharkey

1 reference

9 September 2017

David M Goldenberg

5

1 reference

9 September 2017

William J McBride

series ordinal

7

1 reference

9 September 2017

Edmund A Rossi

series ordinal

8

1 reference

9 September 2017

publication date

15 May 2013

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

9 September 2017

published in

1 reference

9 September 2017

volume

40

1 reference

9 September 2017

issue

9

1 reference

9 September 2017

page(s)

1377-1383

1 reference

https://scigraph.springernature.com/pub.10.1007/s00259-013-2434-7

9 September 2017

exact match

0 references

cites work

Prostate cancer: role of SPECT and PET in imaging bone metastases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

New horizons in prostate cancer imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Specificity and properties of MAb RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

A new Tri-Fab bispecific antibody for pretargeting Trop-2-expressing epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68Ga- and 18F-labeled hapten peptide in mice with human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with 111In in HEPES and MES buffer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Pretargeted 177Lu radioimmunotherapy of carcinoembryonic antigen-expressing human colonic tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2434-7

Bispecific antibody pretargeting PET (immunoPET) with an 124I-labeled hapten-peptide.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23674207

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-013-2434-7

1 reference

9 September 2017

1 reference